Impact of Incidental Cardiac Radiation on Cardiopulmonary Toxicity and Survival for Locally Advanced Non-Small Cell Lung Cancer: Reanalysis of NRG Oncology/RTOG 0617 With Centrally... von Gore, E.M, Hu, C, Ad, V. Bar, Robinson, C.G, Wheatley, M.D, Bogart, J.A, Garces, Y, Kavadi, V.S, Narayan, S, Iyengar, P, Witt, J.S, Welsh, J.W, Koprowski, C.D, Larner, J.M, Bradley, J.D

Volltext

Patient-Reported Outcomes (PROs) in NRG Oncology/RTOG 0436: A Phase 3 Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Esophageal Cancer Treat... von Kachnic, L.A, Moughan, J, Suntharalingam, M, Ilson, D.H, Konski, A.A, Burrows, W, Anker, C, Ad, V. Bar, Thakrar, H.V, Hayes, J.P, Gore, E.M, Kavadi, V.S, Komaki, R.U, Raben, A, Giguere, J.K, Pollock, J, Greenberger, J.S, Videtic, G.M, Roof, K.S, Watkins Bruner, D

Volltext

Comparison of 3-D Conformal and Intensity Modulated Radiation Therapy Outcomes for Locally Advanced Non-Small Cell Lung Cancer in NRG Oncology/RTOG 0617 von Chun, S.G, Hu, C, Choy, H, Komaki, R.U, Timmerman, R.D, Schild, S.E, Bogart, J.A, Dobelbower, M.C, Bosch, W.R, Galvin, J.M, Kavadi, V.S, Narayan, S, Iyengar, P, Robinson, C.G, Wynn, R, Raben, A, Augspurger, M, MacRae, R.M, Paulus, R, Bradley, J.D

Volltext

Quality of Life (QOL) Analysis of the Randomized Radiation (RT) Dose-Escalation NSCLC Trial (RTOG 0617): The Rest of the Story von Movsas, B, Hu, C, Sloan, J, Bradley, J.D, Kavadi, V.S, Narayan, S, Robinson, C, Johnson, D.W, Paulus, R, Choy, H

Volltext

OA17.04 Long-Term Outcomes by Radiation Technique for Locally-Advanced Non-small Lung Cancer: A Secondary Analysis of NRG Oncology-RTOG 0617 at 5-years von Chun, S.G., Hu, C., Choy, H., Komaki, R.U., Timmerman, R.D., Schild, S.E., Bogart, J.A., Dobelbower, M.C., Bosch, W., Kavadi, V.S., Narayan, S., Iyengar, P., Robinson, C.G., Rothman, J., Raben, A., Augspurger, M.E., McRae, R.M., Paulus, R., Bradley, J.D.

Volltext

OA17.05 Association Between Pre-Treatment Circulating Immune Biomarkers And Survival In Stage III NSCLC: A Translational Analysis From NRG-RTOG 0617 von Machtay, M., Hu, C., Schell, T.D., Bradley, J.D., Perdew, G.H., Lu, B., Beidler, L., Dong, F., Jordan, R.C., DeVries, S., Werner Wasik, M., Garces, Y.I., Narayan, S., Robinson, C.G., Rothman, J.M., Raben, A., Kavadi, V.S., Gore, E.M., Wu, T., Kong, F.-M.

Volltext

MA13.01 A Validation Study on DNA Repair Gene Variant for Lung Cancer Survival Prediction after Chemoradiation: A Secondary Analysis for RTOG-0617 Study von Wang, W., Kong, F.(., Hu, C., Jin, J., Machtay, M., Bogart, J., Garces, I.Y., Narayan, S., Robinson, C.G., Kavadi, V.S., Rothman, J., Koprowski, C.D., Gore, E., Welsh, J., Gaur, R., Macrae, R.M., Cannon, G., Bradley, J., Lu, B.

Volltext

Radiomic Biomarkers Evaluation of the High Dose Arm of RTOG 0617 von Sasankan, N., Geng, H., Zhong, H., Fan, Y., Rosen, M., Bradley, J.D., Cao, J., Garces, Y., Iyengar, P., Kavadi, V.S., Robinson, C.G., Welsh, J.W., Narayan, S., MacRae, R.M., Gaur, R., Curran, W.J., Videtic, G.M., Pu V, A., Koprowski, C.D., Xiao, Y.

Volltext

The Role of Heart-Related Dose-Volume Metrics on Overall Survival in the RTOG 0617 Clinical Trial von Thor, M., Deasy, J.O., Hu, C., Choy, H., Komaki, R.U., Masters, G., Blumenschein, G.R., Forster, K.M., Oh, J.H., Kavadi, V.S., Narayan, S., Timmerman, R.D., Robinson, C.G., Greenberger, J.S., Biggs, D., Augspurger, M., Meng, J., Bradley, J.D.

Volltext

Higher Radiation Dose to Immune System is Correlated With Poorer Survival in Patients With Stage III Non–small Cell Lung Cancer: A Secondary Study of a Phase 3 Cooperative Group Tr... von Jin, J.Y., Hu, C., Xiao, Y., Zhang, H., Ellsworth, S., Schild, S.E., Bogart, J.A., Dobelbower, M.C., Kavadi, V.S., Narayan, S., Iyengar, P., Robinson, C.G., Brufsky, A.M., Koprowski, C.D., Machtay, M., Curran, W.J., Paulus, R., Choy, H., Bradley, J.D., Kong, F.M.

Volltext

Effect of PTV and Collimator Margins on Tumor Control for Patients with Stage III Non-small Cell Lung Cancer in NRG Oncology RTOG-0617 von Jin, J.Y., Hu, C., Wang, W., Zhang, H., Yu, J., Bentzen, S.M., Deasy, J.O., Xiao, Y., Schild, S.E., Bogart, J.A., Dobelbower, M.C., Michalski, J., Kavadi, V.S., Narayan, S., Iyengar, P., Robinson, C.G., Deutsch, M., Kong, F.M., Choy, H., Bradley, J.D.

Volltext

Lessons Learned From the Two-Step QA Process in NRG Oncology/RTOG 1005, A Phase 3 Trial for Early-Stage Breast Cancer von Li, A., Moughan, J., White, J.R., Freedman, G.M., Arthur, D.W., Galvin, J.M., Xiao, Y., McNulty, S., Lyons, J., Kavadi, V.S., Fields, M.T., Mitchell, M.P., Anderson, B.M., Lock, M.I., Kokeny, K.E., Bazan, J.G., Currey, A.D., Hijal, T., Cheston, S., Vicini, F.A.

Volltext

Long-Term Results of RTOG 0617: A Randomized Phase 3 Comparison of Standard Dose Versus High Dose Conformal Chemoradiation Therapy +/- Cetuximab for Stage III NSCLC von Bradley, J.D., Hu, C., Komaki, R.U., Masters, G., Blumenschein, G.R., Schild, S.E., Bogart, J.A., Forster, K.M., Magliocco, A., Kavadi, V.S., Narayan, S., Iyengar, P., Robinson, C.G., Wynn, R.B., Koprowski, C.D., Olson, M.R., Meng, J., Curran, W.J., Choy, H.

Volltext